Acute calcium ingestion attenuates exercise-induced disruption of calcium homeostasis.
OBJECTIVE
Exercise is associated with a decrease in bone mineral density under certain conditions. One potential mechanism is increased bone resorption due to an exercise-induced increase in parathyroid hormone (PTH), possibly triggered by dermal calcium loss. The purpose of this investigation was to determine whether calcium supplementation either before or during exercise attenuates exercise-induced increases in PTH and C-terminal telopeptide of Type I collagen (CTX; a marker of bone resorption).


METHODS
Male endurance athletes (n = 20) completed three 35-km cycling time trials under differing calcium supplementation conditions: 1) 1000 mg of calcium 20 min before exercise and placebo during, 2) placebo before and 250 mg of calcium every 15 min during exercise (1000 mg total), or 3) placebo before and during exercise. Calcium was delivered in a 1000-mg·L(-1) solution. Supplementation was double-blinded, and trials were performed in random order. PTH, CTX, bone-specific alkaline phosphatase (BAP; a marker of bone formation), and ionized calcium (iCa) were measured before and immediately after exercise.


RESULTS
CTX increased and iCa decreased similarly in response to exercise under all test conditions. When compared with placebo, calcium supplementation before exercise attenuated the increase in PTH (mean ± SE: 55.8 ± 15.0 vs 74.0 ± 14.2 pg·mL(-1), P = 0.04); there was a similar trend (58.0 ± 17.4, P = 0.07) for calcium supplementation during exercise. There were no effects of calcium on changes in CTX, BAP, and iCa.


CONCLUSIONS
Calcium supplementation before exercise attenuated the disruption of PTH. Further research is needed to determine the effects of repeated increases in PTH and CTX on bone (i.e., exercise training) and whether calcium supplementation can diminish any exercise-induced demineralization.
Barry
Daniel W
DW
Department of Medicine, Division of General Internal Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. daniel.barry@ucdenver.edu
Hansen
Kent C
KC
van Pelt
Rachael E
RE
Witten
Michael
M
Wolfe
Pamela
P
Kohrt
Wendy M
WM
D000328:Adult; D001642:Bicycling; D002136:Calcium, Dietary / Q000008:administration & dosage* / Q000494:pharmacology; D004311:Double-Blind Method; D015444:Exercise / Q000502:physiology*; D006706:Homeostasis / Q000187:drug effects*; D006801:Humans; D008297:Male; D010281:Parathyroid Hormone / Q000378:metabolism*; D013542:Sweat / Q000737:chemistry
D002136:Calcium, Dietary; D010281:Parathyroid Hormone
J Bone Miner Res. 2008 Apr;23(4):484-91
18072875
Calcif Tissue Int. 1997 Jan;60(1):16-20
9030474
Rev Endocr Metab Disord. 2000 Nov;1(4):307-15
11706745
Osteoporos Int. 2003 Aug;14(8):644-9
12856112
Calcif Tissue Int. 1996 Apr;58(4):221-5
8661951
Exp Physiol. 2000 Nov;85(6):869-75
11187982
Int J Sports Med. 2006 Feb;27(2):105-11
16475055
Scand J Med Sci Sports. 1997 Jun;7(3):152-9
9200319
J Bone Miner Res. 2009 Aug;24(8):1380-8
19257829
Calcif Tissue Int. 2007 Jun;80(6):359-65
17549534
Sports Med. 1993 Nov;16(5):316-30
8272687
J Appl Physiol. 1973 Jan;34(1):102-6
4697366
Metabolism. 2008 Feb;57(2):226-32
18191053
J Sci Med Sport. 2009 Jul;12(4):463-7
18768364
JAMA. 1996 Jul 17;276(3):226-30
8667568
Am J Med. 1971 May;50(5):567-88
4325018
Med Sci Sports Exerc. 1996 Feb;28(2):266-70
8775164
J Clin Endocrinol Metab. 1990 Jan;70(1):252-63
2294134
J Occup Environ Med. 2000 Nov;42(11):1054-9
11094783
Calcif Tissue Int. 2004 May;74(5):407-14
14735261
Br J Sports Med. 2005 Aug;39(8):497-502
16046330